Over the course of this season, one thing has kept coming up across all the episodes - the power of big data in health tech. From its uses in the current AI revolution, to universal health records and even in new sustainable practices, the way in which huge data sets are allowing health practitioners to create new products and services is as fascinating as it is exciting. 

So in this season’s final episode, we take a look at the kind of utopian world that could exist when data is harnessed properly in the entire healthcare ecosystem, and what the roadmap to getting there looks like.

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Giovanna Jaramillo-Gutierrez

Giovanna is an epidemiologist researcher and a data scientist who began work as a molecular biologist, before moving into epidemiology. She works at the intersection of epidemiology and AI and is passionate about the development of ethical, human-centered, AI-based products and services. She has worked across the globe for various international organisations including the WHO and Eticas Consulting, amongst others. Get in touch with Giovanna on LinkedIn

Anthony Sitaš

Anthony is a consultant at TTP who works across digital health strategy and design and product development partnerships. His focus lies within the areas of psychology, neuroscience, clinical decision support systems and algorithmic explainability, and he is a passionate advocate of both decentralised Healthcare and Preventative and Precision Medicine. Get in touch with Anthony on LinkedIn

The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients. 

Find out more about our work here: https://www.ttp.com/

Speed is not normally something you would associate with the highly regulated world of health tech. “Rapid” time frames tend to be in the space of 3-5 years. But the Covid panic changed this - the war footing it caused brought times down enormously. It’s something that TTP played a hand in as well with Covent, TTP’s rapid manufacture ventilator for COVID-19 patients. So what can we learn from this period to bring to normal times? How can health tech practitioners work with regulators and the NHS to ensure new innovations move from idea to impact as quickly as possible? How can we achieve truly rapid innovation?

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Dr. Edwin Stone

Dr. Edwin Stone is a consultant at TTP who now leads Cellular Origins, a TTP spin-out created to enable scalable and cost-effective manufacture of cell and gene therapies. Before this, he worked on some of the earliest EMA-approved cell therapies and has been involved in the development of over 10 novel cell therapy automation platforms. He was also closely involved in Covent, TTP’s rapid manufacture ventilator for COVID-19 patients. Connect with Edwin on LinkedIn.

Luella Trickett

With over 25 years' experience in the pharmaceutical and HealthTech industries, Luella’s career has seen her hold numerous specialist manufacturing and commercial roles, with responsibility for a range of product portfolios across the HealthTech spectrum within the UK, Europe, Middle East and Africa. In 2019 she joined the ABHI as their director of value and access, an organisation who represent and support the entire industry to stakeholders, including the government, NHS, and regulators. Connect with Luella on LinkedIn.

The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients. 

Find out more about our work here: https://www.ttp.com/

There’s a multitude of ways to treat Cardiac issues, and it’s about more than just health tech. While technologies that intervene after a cardiac event has taken place are coming on leaps and bounds - from ablation catheters to pacemakers - preventative measures are seen by many as the way forward. Whether it is improved sensing technologies, the rise of telehealth, or even promoting good lifestyle factors, stopping cardiac issues even happening in the first place is a first port of call for many clinicians. But which is more significant? What’s the way forward? And how do we keep patients with cardiac issues out of the hospital?

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Professor Stephen Leslie

Professor Stephen Leslie has been an interventional cardiologist with NHS Highland since 2006, and has research interests that include heart failure and remote and rural service provision. Alongside his clinical work, Stephen is also an honorary professor with The University of the Highlands and Islands and The University of Stirling. Connect with Stephen on LinkedIn.

Simon Calcutt

Simon has been a TTP consultant for the past 8 years, and across that time, he’s been working on medical devices from drug delivery to surgical systems and active implantable devices. His current focus is around implantable devices and utilising sensor technology for real time or near real time monitoring, enabling more personalised medicine, remote patient monitoring and improved standards of care, with cardiac health as one of his main specialities. Connect with Simon on LinkedIn. 

The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients. 

Find out more about our work here: https://www.ttp.com/

Trust in healthcare is one of the highest for any industry, but it’s a different story for the technology sector. People will inherently trust their doctor, but social media, or medical advice from the internet? Much less so. 

But as healthcare and technology become ever more entwined, how do those designing healthcare’s digital products ensure those using them will trust them? What will the consequences of falling trust in technology mean for health tech? 

And what does it take to make you trust someone in general? 

In this episode of Invent: Health, we speak with Dan Lock from TTP and Jordan Abdi from Picnic Health, to unlock the principles of trust and find a paradigm for what this will look like in the future of healthcare.

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Dan Lock - Dan is a principal consultant in human factors at TTP, where he has been for the past 6 years. His background is in psychology with a masters in Ergonomics and Human-Computer Interaction. His primary interests are around human performance, usability, behaviour change, and user experience in medical technology, and he also has a particular focus on supporting design for engagement. Connect with Dan on LinkedIn

Jordan Abdi - Jordan is a World Economic Forum Global Shaper and Schwarzman Scholar who is passionate about preventative health. A medical doctor by background, he has 8+ years' experience working in the health technology sector, and has co-founded think tanks, founded health tech companies, and more. He is currently the Life Sciences Business Development Lead at Picnic Health, a company who tracks health records for patients across the U.S. Connect with Jordan on LinkedIn

The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients. 

Find out more about our work here: https://www.ttp.com/

Medical imaging technologies have long been dominated by big, expensive machines that take up their own room within hospitals. The level of detail they can give is extensive and vital, and they are now even developing new fusion technologies that can combine nuclear, ultrasound, and MRI technologies together. 

But there is a new range of technologies coming into the market which are changing the way we think about imaging. These devices are more portable, and cheaper, allowing true point of care for patients, while also unlocking imaging in new realms of healthcare. 

In this episode of Invent Health, we speak with George Wylde of TTP and Paul Cload of Serac Imaging Systems, to assess the state of play in medical imaging today, to see the benefits and disparities between the new range of machines and the ones which have previously dominated the market. 

Find out more on this week’s episode of Invent Health from TTP.

This Week's Guests:

Paul Cload - Dr. Paul Cload is the chief marketing officer of Seracam Imaging Systems. With over 30 years of experience in the global pharmaceutical medical device and diagnostics industries, Paul brings insight from all areas of the bioscience space to his work with Serac. He has a ​​broad knowledge of multiple therapeutic areas including infectious diseases, cardiovascular disease, oncology, diabetes, and musculoskeletal disease.

George Wylde - George Wylde is a technical consultant at TTP where he combines a passion for medical imaging and sensing inside the body with a love of building things. His experience has spanned from the development of a gamma imaging system for nuclear medicine to a smart orthopaedic implant. Prior to TTP George worked at a family-run scientific instrument company in Sussex developing an instrument to be flown on the next generation of ESA’s meteorological satellites (MetOP-SG MWS). He holds a Biophysics PhD in Embryonic Stem Cell Research from the University of Cambridge.

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com

Sustainability is a word now ubiquitous in healthcare. But too often it is thought about with a short-sighted lens, promoting potentially superficial changes in micro areas over innovations that would reduce healthcare’s carbon footprint on a macro level. So how can we solve this?

What could a new paradigm for discussing sustainability in healthcare look like?

In this episode of Invent Health, we meet the people seeking to create one, by focusing on the wider impact of medical devices to keep people out of hospital, with the potential to reduce carbon footprints on a huge scale.

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Ama Frimpong - Ama Frimpong is the head of product development at 52 North Health - a company that works across the medical device space as they seek to improve health outcomes by reinventing care pathways using affordable, human-centred technologies. With a materials and mechanical engineering background, Ama also has a real grounding in medical devices, from laparoscopic instruments to orthopedics. She was also recently awarded the hugely prestigious ‘young woman engineer of the year’ award for 2022 for her work with 52 North.

Freddie Scott - Freddie Scott is a strong proponent of every industry playing an active role in tackling Climate Change. At TTP, he was part of the passionate sustainability team, who have developed a method for assessing the environmental impact of medical devices in the context of their wider care pathway. By exploring the downstream emissions of products, the scope for design interventions to reduce their environmental impact becomes increasingly broad and impactful; enabling the decarbonisation of healthcare in the shortest time possible.

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com

Neurological disorders have a really significant patient burden, with some estimates suggesting the impact as many as 1 billion people across the globe. But simultaneously, these are diseases which are both challenging to treat and still remain relatively poorly understood.

Snapshots of the brain have been available through imaging technologies for a while, but coming up with devices that are able to monitor the brain in real time has proved a huge challenge.

Today we ask, what will improvements to continuous monitoring devices enable for the diagnosis and treatment of neurological disorders?

In the second episode of Invent:Health Season 2, Matt Parker speaks to Alex Stokoe, a neurotechnology consultant at TTP, and Professor Martha Morrell, Clinical Professor of Neurology at Stanford University

This Week's Guests
Alex Stokoe - Alex Stokoe is a neurotechnology consultant at TTP. Working closely with clients, Alex has worked on and led the product development of several medical devices and specializes in next-generation modulation systems, across biosensing, digital health, and neurotechnology markets.

Martha Morrell - Professor Martha Morrell is the Clinical Professor of Neurology at Stanford University. As someone who has spent their entire career working at the forefront of this field, Martha's previous experience is distinguished. Having served in various positions across the university since joining in 2004, Martha has authored and co-authored more than 150 publications. Martha is also the Chief Medical Officer at NeuroPace, a company that has developed a responsive neurostimulator for the treatment of medically uncontrolled partial seizures.

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com

In this first episode of Invent:Health Season 2, Matt Parker speaks to Chris Dawson, Head of Biosensing at TTP, and Dr. Andrew Chapman, CEO, and Co-Founder of Carbometrics, to explore how patients can be taken out of this monitoring-delivery loop and what technologies are out there that can automate the process entirely.

This Week's Guests
Chris Dawson - Dr. Chris Dawson is a mechanical engineer who leads the biosensing team at TTP. The team works with clients to leverage advances in biosensing technology to develop products that support patients in managing and treating a wide range of diseases. They develop sensing solutions from short-term minimally invasive to long-term fully implantable, all with challenging requirements for biocompatibility, hermeticity, form-factor, wireless power & comms, and integrate a broad range of sensing modalities from electrical and electrochemical, through to ultrasonic and optical.

Andrew Chapman - Dr. Andrew Chapman is a scientist and entrepreneur who for over a decade, has designed and led interdisciplinary commercial and academic programs across a whole range of different scientific disciplines. Andrew is currently the CEO and co-founder of Carbometrics, a company whose revolutionary biomimetic glucose binding molecules have made them one of the most exciting companies working in this space.

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com

Doing what’s good for you should seem like second nature, so why is it that we as humans so often don’t do things which we know will be effective when it comes to our own health and wellbeing? From difficulties in quitting smoking to the 25% of prescriptions in the UK that are left unfilled, medical non-adherence has profound effects on the health of a population, and it’s also one of the trickiest realms for health practitioners to deal with. How do you literally change someone’s behaviour if they already know they’re doing themselves harm?

Find out on this week's episode of Invent: Health from TTP.

This Week's Guests
Paul Upham is the Head of Smart Devices at Roche / Genentech and has over 20 years of experience in medical technology and digital health in R&D as well as global marketing and product management roles, including leading the development of the world's first prescription digital therapy for type 2 diabetes, Bluestar, from WellDoc.
https://www.linkedin.com/in/paulupham/

Dan Lock is a consultant in psychology and human factors at TTP. A psychologist by background, Dan leads on understanding the users of our products, exploring their motivations and figuring out those design features that translate into long-term adherence to medication.
https://www.linkedin.com/in/danlock/

Dr. Olga Perski is an interdisciplinary scientist working at the intersection of behavioural science and digital health. She is a health psychologist by training and completed her PhD at University College London in 2018, with a thesis on the definition, measurement and promotion of user engagement with digital behaviour change interventions. She is a post-doc in the UCL Tobacco and Alcohol Research Group and a UCL Centre for Behaviour Change Associate. Her work is focused on the development and evaluation of digital interventions for smoking cessation and alcohol reduction.
https://www.olgaperski.com/

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent